venBio Partners LLC

Q2 2025 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    6

  • Value ($000)

    $114,757

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001776382
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

PHARVARIS N V

COM
N69605108
$75.49M
66 %

4,289,304

HRMY
HRMY

HARMONY BIOSCIENCES HLDGS IN

COM
413197104
$15.46M
14 %

489,194

ALMS
ALMS

ALUMIS INC

COM
022307102
$13.86M
12 %

4,619,803

---

LYELL IMMUNOPHARMA INC

COM NEW
55083R203
$4.19M
4 %

473,479

ALXO
ALXO

ALX ONCOLOGY HLDGS INC

COM
00166B105
$4.03M
4 %

9,699,925

---

ARTIVA BIOTHERAPEUTICS INC

COM
04317A107
$1.73M
2 %

1,148,975

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 6 of 6